Sun Pharmaceutical Industries Q2 FY 24 consolidated PAT higher at Rs. 2375.51 Cr
News

Sun Pharmaceutical Industries Q2 FY 24 consolidated PAT higher at Rs. 2375.51 Cr

Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023

  • By IPP Bureau | November 02, 2023

Sun Pharmaceutical Industries Limited has reported Consolidated financial results for the period ended September 30, 2023.

Sun Pharmaceutical Industries has posted net profit of Rs. 2375.51 crores for the period ended September 30, 2023 as against net profit of Rs. 2022.54 crores for the period ended June 30, 2023. The company posted net profit of Rs.2262.22 crores for the period ended September 30, 2022.

Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023 as compared to Rs. 12145.28 crores during the period ended June 30, 2023. The company reported total income of Rs.11037.50 crores during the period ended September 30, 2022.

For the Half Year ended September 30, 2023, Sun Pharmaceutical Industries has reported total income of Rs.24631.30 crores as compared to Rs.21801.40 crores during the 6 Months period ended September 30, 2022.

The company has posted net profit f Rs.4398.05 crores for the 6 Months period ended September 30, 2023 as against net profit of Rs.4323.10 crores for the 6 Months period ended September 30, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization